LEP and pulmonary arterial hypertension: A multitude of factors and conditions can affect E2 metabolism (inflammation, hypoxia/oxidative stress, obesity/insulin resistance/leptin, diet, drugs, and genetic polymorphisms of metabolizing enzymes), suggesting that PAH heterogeneity may be due, at least in part, to dysregulated E2 metabolism.